Treatment: The first-line therapy is with oral corticosteroids. The use of steroid-sparing agents early in the course of the disease may help decrease steroid-induced side effects. Cyclophosphamide is the major steroid-sparing agent used. Therapy for polyarteritis nodosa induced by hepatitis B virus infection is targeted at the replicating viral particles.